With an Arsenal of Talent and Scientific Leadership, Why Has Pfizer's Performance Been Disappointing?
Pfizer has many talented scientists and some of the very best R&D leaders in the industry. It also sells truly innovative drugs, such as the cancer meds Xalkori, Inlyta and Ibrance and the vaccine Prevnar. It is one of the heaviest R&D spenders in the industry, with $8.4 billion invested in 2014, and over $80 billion over the last 10 years.